We serve Chemical Name:4,6-Dichloroquinoline CAS:4203-18-3 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:4,6-Dichloroquinoline
CAS.NO:4203-18-3
Synonyms:Quinoline, 4,6-dichloro-;4,6-Dichloroquinoline
Molecular Formula:C9H5Cl2N
Molecular Weight:198.049
HS Code:2933499090
Physical and Chemical Properties:
Melting point:104-105ºC
Boiling point:282.0±20.0 °C at 760 mmHg
Density:1.4±0.1 g/cm3
Index of Refraction:1.661
PSA:12.89000
Exact Mass:196.979904
LogP:3.61
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:UN 2811 6.1 / PGIII
Packing Group:
Contact us for information like Quinoline, 4,6-dichloro- chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,4,6-Dichloroquinoline physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,4,6-Dichloroquinoline Use and application,Quinoline, 4,6-dichloro- technical grade,usp/ep/jp grade.
Related News: Eli Lilly and Roche have been riding high this week on the controversial approval of Biogen’s anti-amyloid Alzheimer’s disease drug Aduhelm (aducanumab), as its new low bar could help these Big Pharmas jump the finish line. 4,6-Dichloroquinoline manufacturer This dosage form may also support combination therapy modalities.? To date, over 400 patients have been dosed with the oral formulation of rigosertib in clinical trials.? Combination therapy of oral rigosertib with azacitidine, the standard of care in HR-MDS, has also been studied. Currently, oral rigosertib is being developed as a combination therapy together with azacitidine for patients with higher-risk MDS who require HMA therapy.? 4,6-Dichloroquinoline supplier Eli Lilly and Roche have been riding high this week on the controversial approval of Biogen’s anti-amyloid Alzheimer’s disease drug Aduhelm (aducanumab), as its new low bar could help these Big Pharmas jump the finish line. 4,6-Dichloroquinoline vendor Speaking to Sky News, Raab said he could not confirm the ��precise number�� of those arriving into the UK on Sunday. 4,6-Dichloroquinoline factory The survival benefit is “unprecedented” for an aging myeloma population, almost all of whom were 65 years of age or older, said Craig Tendler, M.D., vice president of oncology clinical development and global medical affairs at J&J’s Janssen unit, during an interview.
